Late June, Apeloa Pharmaceutical – Hengdian Group’s key pharmaceutical development platform - met with top pharma firms from around the world in Shanghai for CPHI China 2025, the 23rd Chinese edition of the world’s largest pharmaceutical exhibition.

At this year’s CPHI, Apeloa representatives spoke broadly and deeply with visitors and clients about pharmaceutical strategy, product quality and technological innovation. Hundreds of meetings took place at Apeloa’s open-plan exhibitor booth, which mixed greenery with modernity to create a clean, layered and detailed look.

Hengdian Group’s Vice President Wu Xing and Apeloa Pharmaceutical Chairman, CEO Brian Zhu joined their teams at CPHI China to network and engage with healthcare professionals from around the world on topics like pharmaceutical sustainability and market growth.

In particular, Apeloa emphasized its strengths as a core global API supplier and its commitment to outstanding CDMO service. In addition, Apeloa shared insights about its progress in affordable medicine production and key developments in cosmetic raw materials.

Apeloa Pharmaceutical is one of China’s leading pharmaceutical businesses, founded in 1989. It is engaged in four main business areas: active pharmaceutical ingredients (API), contract development and manufacturing organization (CDMO), finished dosage form (FDF) and aesthetics & care ingredients (ACI).

CPHI China represents all stages of the pharmaceutical supply chain, including ingredients, FDF, machinery, packaging, outsourcing and biopharmaceuticals. It presents a valuable opportunity for healthcare experts from around the world to gather to advance and improve the world’s pharmaceutical market.

At the exhibition, Apeloa was invited to take part in multiple expert panels, workshops and interviews. Among them, Apeloa’s head of API Mr. Ray Li and Assistance President of API Ms. Janet Huang shared extensive insights at the “Pharma APIs Internationalized Salon” and “CPHI Expert Interview,” respectively.

Apeloa Pharmaceutical also took part in the CPHI Celebration Awards & Networking Party hosted by CPHI China 2025. At the event, Apeloa was presented with the 2025 CPHI China Pharma Award for Leading Enterprise of Pharma Internationalization. 500 other pharmaceutical professionals and experts from China and overseas also joined in celebrating the remarkable achievements in all sectors of the industry.